Literature DB >> 18296065

Changes in miRNA expression in solid tumors: an miRNA profiling in melanomas.

Viktor Molnár1, Viola Tamási, Beáta Bakos, Zoltán Wiener, András Falus.   

Abstract

In this review, we briefly described microRNA biogenesis, function and the principal approaches for studying the function of microRNAs (miRNA) in solid cancers. There are currently hundreds of confirmed miRNAs in humans, and computational predictions suggest that the total count might be more than thousand. The regulatory nature of miRNAs combined with the large number of presumptive target genes suggests that they are essential regulators of a wide range of cellular processes. To illustrate the importance of miRNA-mediated regulation in solid cancer some confirmed interactions were collected. Their relevance is described in detail in melanomas from the aspect of diagnosis, the potential application of miRNAs as biomarkers and as potential therapeutic tools.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296065     DOI: 10.1016/j.semcancer.2008.01.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  22 in total

Review 1.  The role of microRNAs in skin fibrosis.

Authors:  Olubukola Babalola; Andrew Mamalis; Hadar Lev-Tov; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2013-11       Impact factor: 3.017

Review 2.  Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s.

Authors:  Viola Tamási; Katalin Monostory; Russell A Prough; András Falus
Journal:  Cell Mol Life Sci       Date:  2010-12-24       Impact factor: 9.261

3.  Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription.

Authors:  Xiaoqing Tang; Latha Muniappan; Guiliang Tang; Sabire Ozcan
Journal:  RNA       Date:  2008-12-18       Impact factor: 4.942

4.  MicroRNA in Melanoma.

Authors:  Paul M Howell; Xiaobo Li; Adam I Riker; Yaguang Xi
Journal:  Ochsner J       Date:  2010

5.  Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models.

Authors:  Daniela Dettori; Francesca Orso; Elisa Penna; Désirée Baruffaldi; Serena Brundu; Federica Maione; Emilia Turco; Enrico Giraudo; Daniela Taverna
Journal:  Mol Ther       Date:  2018-08-01       Impact factor: 11.454

6.  Analysis of the miR-34a locus in 62 patients with familial cutaneous melanoma negative for CDKN2A/CDK4 screening.

Authors:  Angela M Cozzolino; Lucia Pedace; Marco Castori; Paola De Simone; Nicoletta Preziosi; Isabella Sperduti; Chiara Panetta; Valerio Mogini; Carmelilia De Bernardo; Aldo Morrone; Caterina Catricalà; Paola Grammatico
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

Review 7.  miR-214 as a key hub that controls cancer networks: small player, multiple functions.

Authors:  Elisa Penna; Francesca Orso; Daniela Taverna
Journal:  J Invest Dermatol       Date:  2014-12-11       Impact factor: 8.551

Review 8.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 9.  Role of miRNAs in the progression of malignant melanoma.

Authors:  D W Mueller; A K Bosserhoff
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

10.  Challenge and promise: the role of miRNA for pathogenesis and progression of malignant melanoma.

Authors:  Salma Essa; N Denzer; U Mahlknecht; R Klein; E M Collnot; J Reichrath
Journal:  Clin Epigenetics       Date:  2010-05-08       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.